(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
Live Chart Being Loaded With Signals
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD)...
Stats | |
---|---|
本日の出来高 | 55 967.00 |
平均出来高 | 155 411 |
時価総額 | 185.01M |
EPS | $0 ( 2024-04-02 ) |
次の収益日 | ( $-0.130 ) 2024-05-16 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -6.16 |
ATR14 | $0.0130 (0.48%) |
ボリューム 相関
CARDIOL THERAPEUTICS INC 相関 - 通貨/商品
CARDIOL THERAPEUTICS INC 財務諸表
Annual | 2023 |
収益: | $0 |
総利益: | $-248 355 (0.00 %) |
EPS: | $-0.440 |
FY | 2023 |
収益: | $0 |
総利益: | $-248 355 (0.00 %) |
EPS: | $-0.440 |
FY | 2022 |
収益: | $0 |
総利益: | $-219 908 (0.00 %) |
EPS: | $-0.180 |
FY | 2021 |
収益: | $78 760.00 |
総利益: | $0.00 (0.00 %) |
EPS: | $-0.730 |
Financial Reports:
No articles found.
CARDIOL THERAPEUTICS INC
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx as a cardioprotective therapy to reduce cardiovascular and respiratory events in patients hospitalized with COVID-19, as well as to evaluate the efficacy and safety of CardiolRx in acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。